Sociedad Americana de Hirudoterapia

Ministerio de Salud de Costa Rica — Dirección de Regulación de Productos de Interés Sanitario

MS-DRPIS · Costa Rica · latin america

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Costa Rica's Ministry of Health drug and device registry — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
latin america
Country
Costa Rica
Leech status
unregulated
Last ASH review
2026-05-26

Relevant Regulation Codes

  • Costa Rican Ley General de Salud
  • Costa Rican national medical device regulatory framework

Prescriber Requirements

  • Colegio de Médicos y Cirujanos de Costa Rica–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Ministry of Health registration as applicable; Spanish-language labelling. Standard cold-chain conditions.

Import/Export Rules

Ministry of Health import authorisation; SENASA (Servicio Nacional de Salud Animal) clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Not covered under public insurance schemes for leech therapy specifically.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Costa Rica's Caja Costarricense de Seguro Social (CCSS) provides universal coverage but does not enumerate hirudotherapy as a covered modality based on ASH review.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.